If you are wondering whether Agilent Technologies is attractively priced right now, the key question is whether the current share price lines up with the cash flows and assets you are actually paying ...

Agilent Technologies (A) has drawn fresh attention after launching its S540MD Slide Scanner System in key European markets, a digital pathology scanner that uses AI-assisted tissue detection to ...

Fintel reports that on January 20, 2026, HSBC initiated coverage of Agilent Technologies (NYSE:A) with a Buy recommendation.

Agilent Technologies has launched the Agilent S540MD Slide Scanner System, a high-throughput whole slide imaging scanner with AI-assisted tissue detection, now available in key European markets to ...

Collaboration with Hamamatsu brings next-level speed and scalability to European pathology labs Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent S540MD Slide Scanner ...

This was the stock's sixth consecutive day of losses.

Thermo Fisher Scientific has received a total of 8 ratings from analysts, with the consensus rating as Buy. With an average ...

Agilent Technologies is a broad-based life science and analytical instrument company with a product portfolio spanning chromatography (GC/LC), mass spectrometry, spectroscopy, lab automation, vacuum ...

As a global leader in laboratory technologies, Agilent is committed to helping scientists bring great science to life.

Fintel reports that on January 5, 2026, Evercore ISI Group upgraded their outlook for Agilent Technologies (NYSE:A) from In-Line to Outperform. Analyst Price Forecast Suggests 19.41% Upside As of ...

Qiagen is a consumable molecular diagnostics and life-science tools platform and offers QuantiFERON, QIAstat-Dx, QIAcuity ...